<bill session="115" type="h" number="5568" updated="2023-01-11T13:39:49Z">
  <state datetime="2018-04-18">REFERRED</state>
  <status>
    <introduced datetime="2018-04-18"/>
  </status>
  <introduced datetime="2018-04-18"/>
  <titles>
    <title type="display">National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018</title>
    <title type="official" as="introduced">To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.</title>
    <title type="short" as="introduced">National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018</title>
  </titles>
  <sponsor bioguide_id="P000034"/>
  <cosponsors>
    <cosponsor bioguide_id="G000558" joined="2018-04-18"/>
  </cosponsors>
  <actions>
    <action datetime="2018-04-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-04-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Educational facilities and institutions"/>
    <term name="Government information and archives"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Higher education"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
    <term name="Product development and innovation"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-20T17:20:10Z" status="Introduced in House">National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)</summary>
</bill>
